Save time and get answers to complex questions with AI chat
Motegrity ingredients?Can wine consumption affect lipitor's cholesterol lowering ability?Drug patent watch trametinib?Defense strategy against generic in niche market?How much is mebendazole?
See the DrugPatentWatch profile for Entresto
Entresto is a prescription medicine that contains two active ingredients: sacubitril and valsartan. It’s used to treat certain types of heart failure. [1]
Entresto combines: - Sacubitril: helps increase protective natriuretic peptides in the body by blocking their breakdown. - Valsartan: blocks angiotensin II receptors (an ARB), which helps relax blood vessels and reduce strain on the heart. [1]
Entresto is prescribed for adults with heart failure, including: - Heart failure with reduced ejection fraction (HFrEF) - Heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), in eligible patients [1]
Entresto is a branded medication (sacubitril/valsartan). Information about its patent situation and exclusivity is tracked by DrugPatentWatch.com. [2]
Other Questions About Entresto :